AdaptHealth director granted 18,999 RSUs

AdaptHealth Corp. director David Solomon Williams III received a grant of 18,999 shares of common stock on June 24, 2026, recorded as restricted stock units that will settle in common shares upon vesting.

Rhea-AI Filing Summary

AdaptHealth Corp. director David Solomon Williams III received a grant of 18,999 shares of common stock on June 24, 2026, recorded as restricted stock units that will settle in common shares upon vesting. The grant carried a price of $0.00 per share, reflecting equity-based compensation rather than a market purchase. Following this award, Williams has 64,044 shares of AdaptHealth common stock reported as directly owned, indicating this filing reflects a compensation-related acquisition, not an open-market transaction.

Insider Trade Summary

Grant/Award: 18,999 shares

Grant/Award 1 txn

Insider Williams David Solomon III

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,999	$0.00	$0.00

Holdings After Transaction: Common Stock — 64,044 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Key Figures

RSU grant size: 18,999 shares Grant price: $0.00 per share Post-grant holdings: 64,044 shares

3 metrics

RSU grant size 18,999 shares Restricted stock units granted on June 24, 2026

Grant price $0.00 per share Equity compensation grant, not a market purchase

Post-grant holdings 64,044 shares Total AdaptHealth common shares reported after transaction

Key Terms

restricted stock units, Form 4, equity-based compensation, grant, award, or other acquisition

4 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

equity-based compensation financial

"reflecting equity-based compensation rather than a market purchase."

Equity-based compensation is pay given to employees or contractors in the form of company ownership—such as stock, stock options, or restricted shares—instead of or in addition to cash. It matters to investors because it aligns workers’ interests with shareholders (like giving employees a slice of the company pie), but can also dilute existing owners and appears as a real cost on financial statements, affecting earnings and share value.

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for David Solomon Williams III?

AdaptHealth reported that director David Solomon Williams III received a grant of 18,999 restricted stock units on June 24, 2026. These units are equity compensation and will be settled in common stock when they vest, rather than representing an open-market share purchase.

How many AdaptHealth (AHCO) shares does David Solomon Williams III hold after this Form 4?

After the reported grant, David Solomon Williams III is shown holding 64,044 shares of AdaptHealth common stock. This total includes the 18,999 restricted stock units awarded, which will convert into common shares upon vesting as part of his director compensation.

Was cash involved in the AdaptHealth (AHCO) Form 4 transaction for David Solomon Williams III?

No cash changed hands in this transaction. The 18,999 restricted stock units were granted at a stated price of $0.00 per share, indicating a non-cash equity compensation award rather than a market buy or sell of AdaptHealth common stock.

What type of equity did AdaptHealth (AHCO) grant to director David Solomon Williams III?

AdaptHealth granted David Solomon Williams III restricted stock units that will settle in common stock upon vesting. Restricted stock units typically vest over time or upon meeting conditions, aligning director compensation with company performance and long-term shareholder interests.

Does the AdaptHealth (AHCO) Form 4 show any stock sales by David Solomon Williams III?

The Form 4 shows no stock sales by David Solomon Williams III. It reports only an acquisition coded as a grant or award of 18,999 restricted stock units, with zero sell transactions and no disposal of AdaptHealth common shares in this filing.

Is the AdaptHealth (AHCO) insider transaction a market signal or routine compensation?

The transaction appears to be routine compensation. It is coded as a grant or award acquisition of 18,999 restricted stock units at $0.00 per share, which typically reflects standard director equity compensation rather than a discretionary market trade in AdaptHealth shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:20 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams David Solomon III

(Last) (First) (Middle)

6272 CONDON AVE

(Street)

LOS ANGELES CALIFORNIA 90056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		18,999(1)	A	$0	64,044	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for David S. Williams III	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)